For patients with triple-negative breast cancer (TNBC), neoadjuvant carboplatin plus
Celiac disease might be cured by restoring immune tolerance to gliadin
Celiac disease affects 0.3-2.4% of people in most countries world-wide,
Health Tip: Teach Your Kids Tolerance
— As the world becomes more diverse, parents should teach